• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC VITEK® 2 AST-P631 TEST KIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC VITEK® 2 AST-P631 TEST KIT Back to Search Results
Model Number 414961
Device Problem False Negative Result (1225)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Event Description
A customer in (b)(6) notified biomérieux of discrepant results associated with vitek® 2 ast-p631 test kit (reference 414961).The customer reported that the vitek®2 reported a false negative result for (b)(6).The sample was a blood culture, and the test was performed twice on the vitek® 2.Additional testing was conducted on the plp2a test from alere and the test detected (b)(6) both test times.Pcr from cepheid performed directly from the blood bottle also identified (b)(6).There is no indication or report from the laboratory or physician that the discrepant result led to any adverse event related to a patient's state of health.An internal biomérieux investigation will be initiated.
 
Manufacturer Narrative
A customer in (b)(6) notified biomérieux of a false negative result for msra associated with vitek® 2 ast-p631 test kit (reference 414961).The customer submitted the strain and cards for evaluation.An investigation was performed.The investigation was initiated due to a false susceptible oxacillin (oxa) and false negative cefoxitin screen test (oxsf) on ast-p631 card, which lead to a non-detection of (b)(6) strain on vt2 v7.01.The pcr meca (b)(6) confirmed the presence of a (b)(6) strain.The reference method (agar dilution) gave a susceptible result (0.5mg/l s).Vitek® 2 ast-p631 cards (customer lot, cl 7310221103 and random lot, rl 731398312) were tested and gave an oxa mic = 0.5 mg/l s, an oxsf test negative and a "wild" phenotype.The customer results were duplicated in-house.The oxa vitek® 2 results are in essential agreement when comparing to the reference result (oxa ref mic = 0.5mg/l s).The oxsf test negative is in essential agreement error comparing to the reference method (resistant result on cefoxitin kirby-bauer).In conclusion, there is a presence of a mrsa strain with a low level of resistance, not detected on vitek® 2.The isolate exhibits atypical growth behavior.The vitek® 2ast-p631 cards performed as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 AST-P631 TEST KIT
Type of Device
VITEK® 2 AST-P631 TEST KIT
Manufacturer (Section D)
BIOMERIEUX, INC
595 anglum road
saint louis MO 63042
Manufacturer (Section G)
BIOMERIEUX, INC
595 anglum road
saint louis MO 63042
Manufacturer Contact
ellen weltmer
595 anglum road
saint louis, MO 63042
MDR Report Key6631951
MDR Text Key77559495
Report Number1950204-2017-00189
Device Sequence Number1
Product Code LON
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
N50510: S118
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 09/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/05/2018
Device Model Number414961
Device Lot Number7310221103
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/29/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/03/2017
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-